These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 14712400)
1. Perinecrotic glioma proliferation and metabolic profile within an intracerebral tumor xenograft. Gorin F; Harley W; Schnier J; Lyeth B; Jue T Acta Neuropathol; 2004 Mar; 107(3):235-44. PubMed ID: 14712400 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of dimethylarginine dimethylaminohydrolase enhances tumor hypoxia: an insight into the relationship of hypoxia and angiogenesis in vivo. Kostourou V; Troy H; Murray JF; Cullis ER; Whitley GS; Griffiths JR; Robinson SP Neoplasia; 2004; 6(4):401-11. PubMed ID: 15256062 [TBL] [Abstract][Full Text] [Related]
3. [Hydrogen sulfide stimulates the development of rat glioblastoma]. Li ZY; Liu SC; Xu PJ; Yang Z; Zhang T Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):254-8. PubMed ID: 22781035 [TBL] [Abstract][Full Text] [Related]
4. Protective role of glucose-6-phosphate dehydrogenase activity in the metabolic response of C6 rat glioma cells to polyunsaturated fatty acid exposure. Ramos KL; Colquhoun A Glia; 2003 Aug; 43(2):149-66. PubMed ID: 12838507 [TBL] [Abstract][Full Text] [Related]
6. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. de Groot JF; Liu TJ; Fuller G; Yung WK Cancer Res; 2005 Mar; 65(5):1934-40. PubMed ID: 15753393 [TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of the high affinity glutamate transporter GLT-1 in C6 glioma cells delays tumour progression in rat. Vanhoutte N; Abarca-Quinones J; Jordan BF; Gallez B; Maloteaux JM; Hermans E Exp Neurol; 2009 Jul; 218(1):56-63. PubMed ID: 19374901 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional targeting of acute hypoxia in the tumour stroma is a novel and viable strategy for cancer gene therapy. Ingram N; Porter CD Gene Ther; 2005 Jul; 12(13):1058-69. PubMed ID: 15800661 [TBL] [Abstract][Full Text] [Related]
9. Quantification and distribution of neovascularization following microinjection of C6 glioma cells in rat brain. Péoc'h M; Le Duc G; Trayaud A; Farion R; Le Bas JF; Pasquier B; Rémy C Anticancer Res; 1999; 19(4B):3025-30. PubMed ID: 10652587 [TBL] [Abstract][Full Text] [Related]
10. Metabolic mode peculiar to Meckel's cartilage: immunohistochemical comparisons of hypoxia-inducible factor-1alpha and glucose transporters in developing endochondral bones in mice. Sakakura Y; Shibui T; Irie K; Yajima T Eur J Oral Sci; 2008 Aug; 116(4):341-52. PubMed ID: 18705802 [TBL] [Abstract][Full Text] [Related]
11. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells. Kim DK; Kim IJ; Hwang S; Kook JH; Lee MC; Shin BA; Bae CS; Yoon JH; Ahn SG; Kim SA; Kanai Y; Endou H; Kim JK Neurosci Res; 2004 Dec; 50(4):437-46. PubMed ID: 15567481 [TBL] [Abstract][Full Text] [Related]
12. HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization. Dragowska WH; Warburton C; Yapp DT; Minchinton AI; Hu Y; Waterhouse DN; Gelmon K; Skov K; Woo J; Masin D; Huxham LA; Kyle AH; Bally MB Mol Cancer Res; 2004 Nov; 2(11):606-19. PubMed ID: 15561777 [TBL] [Abstract][Full Text] [Related]
13. The increase in gap junctional communication decreases the rate of glucose uptake in C6 glioma cells by releasing hexokinase from mitochondria. Sánchez-Alvarez R; Tabernero A; Medina JM Brain Res; 2005 Mar; 1039(1-2):189-98. PubMed ID: 15781061 [TBL] [Abstract][Full Text] [Related]
14. Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Gillespie DL; Whang K; Ragel BT; Flynn JR; Kelly DA; Jensen RL Clin Cancer Res; 2007 Apr; 13(8):2441-8. PubMed ID: 17438103 [TBL] [Abstract][Full Text] [Related]
15. Metabolic anatomy of brain: a comparison of regional capillary density, glucose metabolism, and enzyme activities. Borowsky IW; Collins RC J Comp Neurol; 1989 Oct; 288(3):401-13. PubMed ID: 2551935 [TBL] [Abstract][Full Text] [Related]
16. Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells. Wang P; Yu JP; Gao SY; An XM; Ren XB; Wang XG; Li WL Cell Immunol; 2008; 253(1-2):59-65. PubMed ID: 18522858 [TBL] [Abstract][Full Text] [Related]
17. Screening of biochemical/histological changes associated to C6 glioma tumor development by FTIR/PCA imaging. Beljebbar A; Dukic S; Amharref N; Manfait M Analyst; 2010 May; 135(5):1090-7. PubMed ID: 20419261 [TBL] [Abstract][Full Text] [Related]
18. Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system. Maeda M; Namikawa K; Kobayashi I; Ohba N; Takahara Y; Kadono C; Tanaka A; Kiyama H Brain Res; 2006 Apr; 1081(1):34-43. PubMed ID: 16529724 [TBL] [Abstract][Full Text] [Related]
19. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells. Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708 [TBL] [Abstract][Full Text] [Related]
20. [Postnatal cell proliferation in the rat cerebrum: immunohistochemical study with bromodeoxyuridine (BrdU)]. Fujita T; Yoshimine T; Hayakawa T; Ushio Y; Takemoto O; Maruno M; Kano M; Mogami H No To Shinkei; 1988 Jul; 40(7):651-5. PubMed ID: 3066383 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]